Danoprevir

• Description :

  A potent, highly selective, orally available, peptidomimetic HCV NS3/4A protease inhibitor with IC50 of 0.2-0.4 nM (GT1a, 1b, 4, 5 and 6), 1.6 nM (GT2b) .

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  731.8312

• Molecular Formula :

  C35H46FN5O9S

• Notes :

  Research use only, not for human use.

• Receptor :

  HCVNS3/4Aprotease

• CAS Number :

  850876-88-9